Lyra Therapeutics (LYRA)
(Delayed Data from NSDQ)
$0.37 USD
-0.01 (-2.61%)
Updated May 20, 2024 04:00 PM ET
After-Market: $0.36 -0.01 (-3.49%) 4:48 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.34 | 0.00% |
Earnings Summary
For their last quarter, Lyra Therapeutics (LYRA) reported earnings of -$0.35 per share, missing the Zacks Consensus Estimate of -$0.26 per share. This reflects a negative earnings surprise of 34.62%. Look out for LYRA's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.34 per share, reflecting a year-over-year decrease of 3.03%.
Earnings History
Price & Consensus
Zacks News for LYRA
Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?
LYRA: What are Zacks experts saying now?
Zacks Private Portfolio Services